e-learning
resources
Milan 2017
Sunday, 10.09.2017
Lung fibrosis: basic science
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Rescue of mutant ABCA3 by small molecular correctors
S. Kinting (München, Germany)
Source:
International Congress 2017 – Lung fibrosis: basic science
Session:
Lung fibrosis: basic science
Session type:
Thematic Poster
Number:
913
Disease area:
Interstitial lung diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Kinting (München, Germany). Rescue of mutant ABCA3 by small molecular correctors. 913
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Identification of a novel water-soluble activator of wild-type and F508del CFTR: GPact-11a
Source: Eur Respir J 2010; 36: 311
Year: 2010
Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator
Source: Eur Respir J, 57 (6) 2002774; 10.1183/13993003.02774-2020
Year: 2021
Rescue of CFTR function impaired by mutations in exon 15
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
Improved CFTR and lung function with VX-770, a novel investigational potentiator of CFTR, in subjects with the G551D-CFTR mutation
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010
Homozygous mutations of ARFGAP1 gene in severe sarcoidosis
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020
CFTR correctors and potentiators: pre-clinical studies in mouse models for CF
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Novel insights into surfactant protein C trafficking revealed through the study of a pathogenic mutant
Source: Eur Respir J, 59 (1) 2100267; 10.1183/13993003.00267-2021
Year: 2022
Description of new CFTR gene’s mutations in patients of Russia
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Large phenotypic spectrum associated with two new deep intronic variants on the CFTR gene
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations
Source: Eur Respir J, 56 (5) 2000205; 10.1183/13993003.00205-2020
Year: 2020
Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation
Source: Eur Respir J 2004; 24: 1072-1073
Year: 2004
Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids
Source: Eur Respir J 2016; 48: 451-458
Year: 2016
Phenotype characterisation of
TBX4
mutation and deletion carriers with neonatal and paediatric pulmonary hypertension
Source: Eur Respir J, 54 (2) 1801965; 10.1183/13993003.01965-2018
Year: 2019
Methylprednisolone pulse treatment influences splicing of SFTPC mRNA and promotes processing of pro-SP-C protein in twins with SFTPC mutation
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Identification and analysis of rare and novel mutations of the alpha-1-antitrypsin gene
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Are KRAS mutations druggable?
Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Year: 2019
Structural and clinical characterization of novel missense variants of SERPINA1 gene causing alpha-1 antitrypsin deficiency
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019
Dramatic improvement by macrolides in surfactant deficiency with ABCA3 mutation
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Haploid genetic screening identifies a novel regulator of BMPR2
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept